Skip to main content

Find Clinical Trials

Home
Conditions
Levodopa Induced Dyskinesia (LID)

Clinical trial condition

Levodopa Induced Dyskinesia (LID)

Explore clinical trials studying Levodopa Induced Dyskinesia (LID). Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Levodopa Induced Dyskinesia (LID) trial results

Completed

Open-Label Safety Study of ADS-5102 in PD Patients With LID

NCT02202551

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: Birmingham, Alabama, United States

Phoenix, Arizona, United States

Scottsdale, Arizona, United States

Sun City, Arizona, United States

View all 87 locations

View Trial Details

Completed

ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)

NCT02136914

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: Birmingham, Alabama, United States

Phoenix, Arizona, United States

Scottsdale, Arizona, United States

Sun City, Arizona, United States

View all 46 locations

View Trial Details

Completed

Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia

NCT02439203

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations: Bloemfontein, South Africa

View Trial Details